Mutational and splicing landscape in a cohort of 43,000 patients tested for hereditary cancer
Carolyn Horton1, Ashley Cass1, Blair R Conner1
1Ambry Genetics. One Enterprise, Aliso Viejo, CA, 92656, USA.
Abstract:
DNA germline genetic testing can identify individuals with cancer susceptibility. However, DNA sequencing alone is limited in its detection and classification of mRNA splicing variants, particularly those located far from coding sequences. Here we address the limitations of splicing variant identification and interpretation by pairing DNA and RNA sequencing and describe the mutational and splicing landscape in a clinical cohort of 43,524 individuals undergoing genetic testing for hereditary cancer predisposition.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Spontaneous and Induced Mutations
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutations
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...


